YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2022 Nov 9

PMID 36350617

Authors

Haiyan Li

Ayushi Singh

Kristin M Perkumas

W Daniel Stamer

Preethi S Ganapathy

Samuel Herberg

Affiliations

Soon will be listed here.

Abstract

Purpose: Elevated transforming growth factor beta2 (TGFβ2) levels in the aqueous humor have been linked to glaucomatous outflow tissue dysfunction. Potential mediators of dysfunction are the transcriptional coactivators, Yes-associated protein (YAP) and transcriptional coactivator with PDZ binding motif (TAZ). However, the molecular underpinnings of YAP/TAZ modulation in Schlemm's canal (SC) cells under glaucomatous conditions are not well understood. Here, we investigate how TGFβ2 regulates YAP/TAZ activity in human SC (HSC) cells using biomimetic extracellular matrix hydrogels, and examine whether pharmacological YAP/TAZ inhibition would attenuate TGFβ2-induced HSC cell dysfunction.

Methods: Primary HSC cells were seeded atop photo-cross-linked extracellular matrix hydrogels, made of collagen type I, elastin-like polypeptide and hyaluronic acid, or encapsulated within the hydrogels. HSC cells were induced with TGFβ2 in the absence or presence of concurrent actin destabilization or pharmacological YAP/TAZ inhibition. Changes in actin cytoskeletal organization, YAP/TAZ activity, extracellular matrix production, phospho-myosin light chain levels, and hydrogel contraction were assessed.

Results: TGFβ2 significantly increased YAP/TAZ nuclear localization in HSC cells, which was prevented by either filamentous-actin relaxation or depolymerization. Pharmacological YAP/TAZ inhibition using verteporfin without light stimulation decreased fibronectin expression and actomyosin cytoskeletal rearrangement in HSC cells induced by TGFβ2. Similarly, verteporfin significantly attenuated TGFβ2-induced HSC cell-encapsulated hydrogel contraction.

Conclusions: Our data provide evidence for a pathologic role of aberrant YAP/TAZ signaling in HSC cells under simulated glaucomatous conditions and suggest that pharmacological YAP/TAZ inhibition has promising potential to improve outflow tissue dysfunction.

Citing Articles

Endothelial cell stiffness and type drive the formation of biomechanically-induced transcellular pores.

Siadat S, Li H, Millette B, Safa B, Wong C, Fard M bioRxiv. 2024; .

PMID: 39554025 PMC: 11565842. DOI: 10.1101/2024.10.23.619950.

Pathological Mechanism and Clinical Therapy Progress of Schlemm's Canal.

Zhou Y, Liu Z, Gao W, Yang Y, Peng Q, Tan H J Ophthalmol. 2024; 2024:9978312.

PMID: 39492954 PMC: 11531356. DOI: 10.1155/2024/9978312.

Three-Dimensional Extracellular Matrix Protein Hydrogels for Human Trabecular Meshwork Cell Studies.

Singh A, Ghosh R, Li H, Geiss M, Yoo H, Strat A Methods Mol Biol. 2024; 2858:17-29.

PMID: 39433663 PMC: 11571287. DOI: 10.1007/978-1-0716-4140-8_2.

Transcriptomic profiling of Schlemm's canal cells reveals a lymphatic-biased identity and three major cell states.

Balasubramanian R, Kizhatil K, Li T, Tolman N, Bhandari A, Clark G Elife. 2024; 13.

PMID: 39422453 PMC: 11488849. DOI: 10.7554/eLife.96459.

The role of YAP/TAZ mechanosignaling in trabecular meshwork and Schlemm's canal cell dysfunction.

Ghosh R, Herberg S Vision Res. 2024; 224:108477.

PMID: 39208753 PMC: 11470804. DOI: 10.1016/j.visres.2024.108477.

References

Fuchshofer R, Tamm E . Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res. 2009; 88(4):683-8. DOI: 10.1016/j.exer.2009.01.005. View

Montecchi-Palmer M, Bermudez J, Webber H, Patel G, Clark A, Mao W . TGFβ2 Induces the Formation of Cross-Linked Actin Networks (CLANs) in Human Trabecular Meshwork Cells Through the Smad and Non-Smad Dependent Pathways. Invest Ophthalmol Vis Sci. 2017; 58(2):1288-1295. PMC: 5341625. DOI: 10.1167/iovs.16-19672. View

Picht G, Grehn F, Lutjen-Drecoll E . Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001; 239(3):199-207. DOI: 10.1007/s004170000252. View

Choi K, Nam J, Kim J, Choi S, Lee Y . Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage. Exp Mol Med. 2020; 52(5):781-792. PMC: 7272420. DOI: 10.1038/s12276-020-0439-4. View

Silver J, Gunay K, Cutler A, Vogler T, Brown T, Pawlikowski B . Injury-mediated stiffening persistently activates muscle stem cells through YAP and TAZ mechanotransduction. Sci Adv. 2021; 7(11). PMC: 7954458. DOI: 10.1126/sciadv.abe4501. View

Perkumas K, Stamer W . Protein markers and differentiation in culture for Schlemm's canal endothelial cells. Exp Eye Res. 2012; 96(1):82-7. PMC: 3296889. DOI: 10.1016/j.exer.2011.12.017. View

Pattabiraman P, Rao P . Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am J Physiol Cell Physiol. 2009; 298(3):C749-63. PMC: 2838580. DOI: 10.1152/ajpcell.00317.2009. View

Boopathy G, Hong W . Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis. Front Cell Dev Biol. 2019; 7:49. PMC: 6468149. DOI: 10.3389/fcell.2019.00049. View

Gharahkhani P, Jorgenson E, Hysi P, Khawaja A, Pendergrass S, Han X . Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat Commun. 2021; 12(1):1258. PMC: 7904932. DOI: 10.1038/s41467-020-20851-4. View

10.

Rao P, Deng P, Kumar J, Epstein D . Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001; 42(5):1029-37. View

11.

Kwon Y, Fingert J, Kuehn M, Alward W . Primary open-angle glaucoma. N Engl J Med. 2009; 360(11):1113-24. PMC: 3700399. DOI: 10.1056/NEJMra0804630. View

12.

Keller K, Bhattacharya S, Borras T, Brunner T, Chansangpetch S, Clark A . Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. Exp Eye Res. 2018; 171:164-173. PMC: 6042513. DOI: 10.1016/j.exer.2018.03.001. View

13.

Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y . Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 2001; 239(2):109-13. DOI: 10.1007/s004170000241. View

14.

Polansky J, Fauss D, ZIMMERMAN C . Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells. Eye (Lond). 2000; 14 ( Pt 3B):503-14. DOI: 10.1038/eye.2000.137. View

15.

McKee C, Wood J, Shah N, Fischer M, Reilly C, Murphy C . The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents. Biomaterials. 2011; 32(9):2417-23. PMC: 3056267. DOI: 10.1016/j.biomaterials.2010.11.071. View

16.

Das A, Fischer R, Pan D, Waterman C . YAP Nuclear Localization in the Absence of Cell-Cell Contact Is Mediated by a Filamentous Actin-dependent, Myosin II- and Phospho-YAP-independent Pathway during Extracellular Matrix Mechanosensing. J Biol Chem. 2016; 291(12):6096-110. PMC: 4813550. DOI: 10.1074/jbc.M115.708313. View

17.

Zeisberg E, Potenta S, Sugimoto H, Zeisberg M, Kalluri R . Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008; 19(12):2282-7. PMC: 2588112. DOI: 10.1681/ASN.2008050513. View

18.

Honjo M, Inatani M, Kido N, Sawamura T, Yue B, Honda Y . A myosin light chain kinase inhibitor, ML-9, lowers the intraocular pressure in rabbit eyes. Exp Eye Res. 2002; 75(2):135-42. DOI: 10.1006/exer.2002.2009. View

19.

Plouffe S, Hong A, Guan K . Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015; 21(4):212-22. PMC: 4385444. DOI: 10.1016/j.molmed.2015.01.003. View

20.

Ma J, Sanchez-Duffhues G, Goumans M, Ten Dijke P . TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering. Front Cell Dev Biol. 2020; 8:260. PMC: 7187792. DOI: 10.3389/fcell.2020.00260. View